Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026)

Lantheus Holdings (LNTH) reported Cash from Investing Activities of $26.0 million for Q1 2026, up 140.78% year-over-year from $10.8 million in Q1 2025, and up 325.77% quarter-over-quarter from -$11.5 million in Q4 2025.

Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Cash from Investing Activities data on file, last reported at $26.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $26.0 million, up 140.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$537.5 million (down 193.37% YoY), and the FY2025 annual result was -$627.2 million, down 177.49% from the prior year.
  • Cash from Investing Activities grew to $26.0 million in Q1 2026 per LNTH's latest filing, from -$11.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $83.2 million in Q3 2023 and troughed at -$319.5 million in Q3 2025.
  • A 5-year average of -$64.6 million and a median of -$20.7 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities slumped 5725.79% in 2022, then jumped 1466.47% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$264.7 million in 2022, then soared by 95.44% to -$12.1 million in 2023, then soared by 45.3% to -$6.6 million in 2024, then tumbled by 74.34% to -$11.5 million in 2025, then jumped by 325.77% to $26.0 million in 2026.
  • Business Quant data shows LNTH's Cash from Investing Activities at $26.0 million in Q1 2026, -$11.5 million in Q4 2025, and -$319.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.99 Mn
Mar 31, 2026 25.99 Mn
Dec 31, 2025 -11.51 Mn
Dec 31, 2025 -11.51 Mn
Sep 30, 2025 -319.47 Mn
Sep 30, 2025 -319.47 Mn
Jun 30, 2025 -232.47 Mn
Jun 30, 2025 -232.47 Mn
Mar 31, 2025 -63.72 Mn
Mar 31, 2025 -63.72 Mn
Dec 31, 2024 -6.60 Mn
Dec 31, 2024 -6.60 Mn
Sep 30, 2024 -67.80 Mn
Sep 30, 2024 -67.80 Mn
Jun 30, 2024 -45.09 Mn
Jun 30, 2024 -45.09 Mn
Mar 31, 2024 -106.53 Mn
Mar 31, 2024 -106.53 Mn
Dec 31, 2023 -12.07 Mn
Dec 31, 2023 -12.07 Mn